How Long Should People With Schizophrenia Take Antipsychotic Drugs?
cont. from
Antipsychotic medications reduce the risk of future psychotic episodes in
patients who have recovered from an acute episode. Even with continued drug
treatment, some people who have recovered will suffer relapses. Far higher
relapse rates are seen when medication is discontinued. In most cases, it would
not be accurate to say that continued drug treatment “prevents” relapses;
rather, it reduces their intensity and frequency. The treatment of severe
psychotic symptoms generally requires higher dosages than those used for
maintenance treatment. If symptoms reappear on a lower dosage, a temporary
increase in dosage may prevent a full-blown relapse.
Because relapse of illness is more likely when antipsychotic medications are
discontinued or taken irregularly, it is very important that people with
schizophrenia work with their doctors and family members to adhere to their
treatment plan. Adherence to treatment refers to the degree to which patients
follow the treatment plans recommended by their doctors. Good adherence involves
taking prescribed medication at the correct dose and proper times each day,
attending clinic appointments, and/or carefully following other treatment
procedures. Treatment adherence is often difficult for people with
schizophrenia, but it can be made easier with the help of several strategies and
can lead to improved quality of life.
There are a variety of reasons why people with schizophrenia may not adhere
to treatment. Patients may not believe they are ill and may deny the need for
medication, or they may have such disorganized thinking that they cannot
remember to take their daily doses. Family members or friends may not understand
schizophrenia and may inappropriately advise the person with schizophrenia to
stop treatment when he or she is feeling better. Physicians, who play an
important role in helping their patients adhere to treatment, may neglect to ask
patients how often they are taking their medications, or may be unwilling to
accommodate a patient’s request to change dosages or try a new treatment. Some
patients report that side effects of the medications seem worse than the illness
itself. Further, substance abuse can interfere with the effectiveness of
treatment, leading patients to discontinue medications. When a complicated
treatment plan is added to any of these factors, good adherence may become even
more challenging.
Fortunately, there are many strategies that patients, doctors, and families
can use to improve adherence and prevent worsening of the illness. Some
antipsychotic medications, including haloperidol (Haldol®),
fluphenazine (Prolixin®),
perphenazine (Trilafon®) and others, are available in long-acting injectable
forms that eliminate the need to take pills every day. A major goal of current
research on treatments for schizophrenia is to develop a wider variety of
long-acting antipsychotics, especially the newer agents with milder side
effects, which can be delivered through injection. Medication calendars or pill
boxes labeled with the days of the week can help patients and caregivers know
when medications have or have not been taken. Using electronic timers that beep
when medications should be taken, or pairing medication taking with routine
daily events like meals, can help patients remember and adhere to their dosing
schedule. Engaging family members in observing oral medication taking by
patients can help ensure adherence. In addition, through a variety of other
methods of adherence monitoring, doctors can identify when pill taking is a
problem for their patients and can work with them to make adherence easier. It
is important to help motivate patients to continue taking their medications
properly.
In addition to any of these adherence strategies, patient and family
education about schizophrenia, its symptoms, and the medications being
prescribed to treat the disease is an important part of the treatment process
and helps support the rationale for good adherence.
What About Side Effects?
Antipsychotic drugs, like virtually all medications, have unwanted effects
along with their beneficial effects. During the early phases of drug treatment,
patients may be troubled by side effects such as drowsiness, restlessness,
muscle spasms, tremor, dry mouth, or blurring of vision. Most of these can be
corrected by lowering the dosage or can be controlled by other medications.
Different patients have different treatment responses and side effects to
various antipsychotic drugs. A patient may do better with one drug than another.
The long-term side effects of antipsychotic drugs may pose a considerably
more serious problem. Tardive dyskinesia (TD) is a disorder characterized by
involuntary movements most often affecting the mouth, lips, and tongue, and
sometimes the trunk or other parts of the body such as arms and legs. It occurs
in about 15 to 20 percent of patients who have been receiving the older,
“typical” antipsychotic drugs for many years, but TD can also develop in
patients who have been treated with these drugs for shorter periods of time. In
most cases, the symptoms of TD are mild, and the patient may be unaware of the
movements.
Antipsychotic medications developed in recent years all appear to have a much
lower risk of producing TD than the older, traditional antipsychotics. The risk
is not zero, however, and they can produce side effects of their own such as
weight gain. In addition, if given at too high of a dose, the newer medications
may lead to problems such as social withdrawal and symptoms resembling
Parkinson’s disease, a disorder that affects movement. Nevertheless, the newer
antipsychotics are a significant advance in treatment, and their optimal use in
people with schizophrenia is a subject of much current research.
continue: Psychosocial Treatments
top .
pages 1 2 3
4 5 6
7 8 .
send to friend .
schizophrenia site
map
Reviewed: 03/2006
|
|